Syros Pharmaceuticals Free Cash Flow (Quarterly) Trends

Syros Pharmaceuticals Inc (SYRS)

5.15 +0.02 (+0.39%) USD | NASDAQ | May 06, 10:54

Free Cash Flow (Quarterly) Chart

Historical Free Cash Flow (Quarterly) Data

View and export this data back to 2015. Upgrade now.

Date	Value
December 31, 2023	-18.60M
September 30, 2023	-31.86M
June 30, 2023	-22.38M
March 31, 2023	-37.14M
December 31, 2022	-31.76M
September 30, 2022	-36.12M
June 30, 2022	-26.29M
March 31, 2022	-30.14M
December 31, 2021	-23.21M
September 30, 2021	-28.44M
June 30, 2021	-26.88M
March 31, 2021	-22.25M
December 31, 2020	-29.95M
September 30, 2020	-15.78M
June 30, 2020	-13.42M
March 31, 2020	-1.551M
December 31, 2019	-18.76M
September 30, 2019	-13.79M

Date	Value
June 30, 2019	-19.42M
March 31, 2019	-20.92M
December 31, 2018	-14.01M
September 30, 2018	-11.05M
June 30, 2018	-14.09M
March 31, 2018	-2.552M
December 31, 2017	-10.63M
September 30, 2017	-9.578M
June 30, 2017	-12.12M
March 31, 2017	-13.22M
December 31, 2016	-9.91M
September 30, 2016	-9.352M
June 30, 2016	-11.45M
March 31, 2016	-12.14M
December 31, 2015	-8.494M
September 30, 2015	-6.176M
June 30, 2015	-6.159M
March 31, 2015	-3.377M

Free Cash Flow Definition

Free cash flow measures the amount of cash left over from a time period after all operational and working capital payments are made. Free cash flow is an important metric because it allows you to view the amount actual cash is available to the company. Free cash flow is also commonly used in valuation calculations like the discounted cash flow valuation model.

Read full definition.

Free Cash Flow (Quarterly) Range, Past 5 Years

-37.14M

Minimum

Mar 2023

-1.551M

Maximum

Mar 2020

-23.57M

Average

-23.21M

Median

Dec 2021

Free Cash Flow (Quarterly) Benchmarks